Modern Pharmaceutical Biotech Restricted is a Hong Kong-based funding holding firm principally engaged in prescription drugs and biotechnology companies. The Firm operates by 5 segments. Genetic Testing Providers phase is engaged within the provision of genetic testing providers within the People’s Republic of China (PRC) and Hong Kong. Bio-Industrial Merchandise phase is engaged within the distribution of bio-industrial merchandise within the PRC. Magnificence Gear and Merchandise phase is engaged within the buying and selling of magnificence gear and merchandise in Hong Kong. Securities Funding phase is engaged in securities funding in Hong Kong and outdoors Hong Kong. Analysis and Improvement phase is engaged within the analysis, growth and commercialization of the oral insulin merchandise.
